Rebound Thrombocytosis after Induction Chemotherapy is a Strong Biomarker for Favorable Outcome in AML Patients

Schnell, Bianca R.; Seipel, Katja; Bacher, Ulrike; Jeker, Barbara; Mueller, Beatrice U.; Banz, Yara; Novak, Urban; Pabst, Thomas (2019). Rebound Thrombocytosis after Induction Chemotherapy is a Strong Biomarker for Favorable Outcome in AML Patients. HemaSphere, 3(2), e180. Wolters Kluwer Health 10.1097/HS9.0000000000000180

[img]
Preview
Text
Rebound_Thrombocytosis_after_Induction.7 (1).pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (1MB) | Preview

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory
04 Faculty of Medicine > Service Sector > Institute of Pathology

UniBE Contributor:

Bacher, Vera Ulrike; Jeker, Barbara; Banz Wälti, Yara; Novak, Urban and Pabst Müller, Thomas Niklaus

Subjects:

600 Technology > 610 Medicine & health
500 Science > 570 Life sciences; biology

ISSN:

2572-9241

Publisher:

Wolters Kluwer Health

Language:

English

Submitter:

Rebeka Gerber

Date Deposited:

30 Oct 2019 15:48

Last Modified:

03 Nov 2019 02:42

Publisher DOI:

10.1097/HS9.0000000000000180

BORIS DOI:

10.7892/boris.134274

URI:

https://boris.unibe.ch/id/eprint/134274

Actions (login required)

Edit item Edit item
Provide Feedback